Behavioral
ABI
Total Trials
3
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Terminated(1)
Other(2)
Detailed Status
unknown2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
terminated133%
unknown267%
Recent Activity
0 active trials
Showing 3 of 3
terminated
FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia
NCT04120610
unknown
The Use of FlowMet-R Technology to Predict Wound Healing in CLI Patients in a Wound Care Center Setting
NCT05455554
unknownnot_applicable
Violence Brief Intervention Pilot v1.1
NCT02394990
Clinical Trials (3)
Showing 3 of 3 trials
NCT04120610
FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia
NCT05455554
The Use of FlowMet-R Technology to Predict Wound Healing in CLI Patients in a Wound Care Center Setting
NCT02394990Not Applicable
Violence Brief Intervention Pilot v1.1
All 3 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 3